Qube Research & Technologies (QRT)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-154,314	Closed	-$3.72M	–	3214
2023 Q1	$3.72M	Buy	154,314 +52,943	+52%	+$664K	0.02%	754
2022 Q4	$1.07M	Buy	+101,371	New	+$818K	0.01%	1202
2021 Q2	–	Sell	-25,270	Closed	-$265K	–	2952
2021 Q1	$265K	Buy	+25,270	New	+$356K	﹤0.01%	1520
2020 Q2	–	Sell	-36,028	Closed	-$331K	–	2073
2020 Q1	$331K	Sell	36,028 -113,364	-76%	-$1.46M	0.01%	700
2019 Q4	$2.23M	Buy	+149,392	New	+$1.33M	0.07%	336

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRVB Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 154,314 shares — an estimated $3.72M sold.

Qube Research & Technologies (QRT) first reported a position in PRVB in Q4 2019 and held it in 5 quarters. The position peaked at $3.72M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Qube Research & Technologies (QRT) reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 154,314 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $3.72M.
Qube Research & Technologies (QRT) first reported a position in Provention Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Qube Research & Technologies (QRT)'s Provention Bio, Inc. Common Stock position peaked at $3.72M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.